1 |
ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin definition[J]. JAMA, 2012, 307 (23): 2526-2533.
|
2 |
Barrot L, Asfar P, Mauny F, et al. Liberal or conservative oxygen therapy for acute respiratory distress syndrome[J]. N Engl J Med, 2020, 382 (11): 999-1008.
|
3 |
刘茜,王荣帅,屈国强,等.新型冠状病毒肺炎死亡尸体系统解剖大体观察报告[J].法医学杂志,2020,36(1):21-23.
|
4 |
George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy[J]. Lancet Respir Med, 2020, 8 (8): 807-815.
|
5 |
Cabler SS, French AR, Orvedahl A. A cytokine circus with a viral ringleader: SARS-CoV-2-associated cytokine storm syndromes[J]. Trends Mol Med, 2020, 26 (12): 1078-1085.
|
6 |
Karki R, Sharma BR, Tuladhar S, et al. Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes[J]. Cell, 2021, 184 (1): 149-168.e17.
|
7 |
Aghasafari P, George U, Pidaparti R. A review of inflammatory mechanism in airway diseases[J]. Inflamm Res, 2019, 68 (1): 59-74.
|
8 |
Babaei F, Nassiri-Asl M, Hosseinzadeh H. Curcumin (a constituent of turmeric): new treatment option against COVID-19[J]. Food Sci Nutr, 2020, 8 (10): 5215-5227.
|
9 |
Soni VK, Mehta A, Ratre YK, et al. Curcumin, a traditional spice component, can hold the promise against COVID-19?[J]. Eur J Pharmacol, 2020 (886): 173551.
|
10 |
Kumari A, Tyagi N, Dash D, et al. Intranasal curcumin ameliorates lipopolysaccharide-induced acute lung injury in mice[J]. Inflammation, 2015, 38 (3): 1103-1112.
|
11 |
Avasarala S, Zhang F, Liu G, et al. Curcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndrome[J]. PLoS One, 2013, 8 (2): e57285.
|
12 |
Chen YQ, Chai YS, Xie K, et al. Curcumin promotes the expression of IL-35 by regulating regulatory T cell differentiation and restrains uncontrolled inflammation and lung injury in mice[J]. Inflammation, 2020, 43 (5): 1913-1924.
|
13 |
Tang SE, Wu SY, Chu SJ, et al. Pre-treatment with ten-minute carbon dioxide inhalation prevents lipopolysaccharide-induced lung injury in mice via down-regulation of Toll-like receptor 4 expression[J]. Int J Mol Sci, 2019, 20 (24): 6293.
|
14 |
Ding Y, Feng Q, Chen J, et al. TLR4/NF-κB signaling pathway gene single nucleotide polymorphisms alter gene expression levels and affect ARDS occurrence and prognosis outcomes[J]. Medicine (Baltimore), 2019, 98 (26): e16029.
|
15 |
姜黎珊,姚明,杨茂宪,等.不同方式下气管内滴注脂多糖方法制作急性呼吸窘迫综合征大鼠模型[J/CD].中华危重症医学杂志(电子版),2019,12(2):80-84.
|
16 |
Rahimifard M, Maqbool F, Moeini-Nodeh S, et al. Targeting the TLR4 signaling pathway by polyphenols: a novel therapeutic strategy for neuroinflammation[J]. Ageing Res Rev, 2017 (36): 11-19.
|
17 |
孙雪东,严一核,褚韦韦,等.高迁移率族蛋白B1/Toll样受体4信号通路在脓毒症大鼠致急性肺损伤中的作用研究[J/CD].中华危重症医学杂志(电子版),2020,13(6):419-426.
|
18 |
Li W, Xu Q, Deng Y, et al. High-mobility group box 1 accelerates lipopolysaccharide-induced lung fibroblast proliferation in vitro: involvement of the NF-κB signaling pathway[J]. Lab Invest, 2015, 95 (6): 635-647.
|
19 |
浦其斌,方强,周建英,等.新型冠状病毒肺炎患者呼吸支持策略:浙大一院方案[J/CD].中华危重症医学杂志(电子版),2020,13(1):15-19.
|
20 |
Vanderheiden A, Ralfs P, Chirkova T, et al. Type Ⅰ and type Ⅲ interferons restrict SARS-CoV-2 infection of human airway epithelial cultures[J]. J Virol, 2020, 94 (19): e00985-20.
|
21 |
Liu Y, Lv J, Liu J, et al. Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19[J]. Cell Res, 2020, 30 (12): 1078-1087.
|
22 |
Rose MC, Voynow JA. Respiratory tract mucin genes and mucin glycoproteins in health and disease[J]. Physiol Rev, 2006, 86 (1): 245-278.
|
23 |
Mall M, Grubb BR, Harkema JR, et al. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice[J]. Nat Med, 2004, 10 (5): 487-493.
|
24 |
杨国彪,孙小军,徐萌敏.纤维支气管镜肺泡灌洗联合振动排痰在重症肺炎机械通气患者中的应用[J/CD].中华危重症医学杂志(电子版),2020,13(2):138-140.
|